Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03051997 · ClinicalTrials.gov registry record · NA

Increasing Caregiver Engagement in Juvenile Drug Courts

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT03051997: Completed NA study, sponsored by Medical University of South Carolina.

NCT03051997 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03051997, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

The purpose of this study is to test a prize-based contingency management intervention for increasing caregiver engagement in juvenile drug court and adolescent drug treatment, and for achieving the ultimate outcomes of reduced substance use and delinquent behavior among drug court-involved youth.

Primary Outcome

This measure reflects the number of positive urine drug screens for THC, amphetamines, methamphetamines, opiates, cocaine, benzodiazepines, MDMA, and oxycodone collected from youth participants. Assessed at baseline and 5 months; data reported for 5-month time point

Interventions

  • BEHAVIORAL Caregiver Contingency Management + Usual Drug Court Treatment
  • BEHAVIORAL Usual Drug Court Treatment

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2017-10-13
Est. Completion 2024-12-12
Phase NA

What the finished NCT03051997 record still lists

NCT03051997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Caregiver Contingency Management + Usual Drug Court Treatment is the first listed.

NCT03051997 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03051997 about?

NCT03051997 is a clinical study titled "Increasing Caregiver Engagement in Juvenile Drug Courts". The purpose of this study is to test a prize-based contingency management intervention for increasing caregiver engagement in juvenile drug court and adolescent drug treatment, and for achieving the ultimate outcomes of reduced substance use and delinquent behavior among drug court-involved youth.

What is the current status of trial NCT03051997?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2017-10-13. Estimated completion is 2024-12-12.

What interventions are being tested in trial NCT03051997?

The interventions under investigation include: Caregiver Contingency Management + Usual Drug Court Treatment (BEHAVIORAL), Usual Drug Court Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03051997?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03051997's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03051997, the US trial registry maintained by the National Library of Medicine. NCT03051997 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.